News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
Future Proofing: Key DIA GAM 2021 Themes Inform Global Pharmacovigilance and Risk Management Strategies 2022
When the DIA community gathered for DIA GAM 2021 last June, the pandemic had turned clinical safety and benefit-risk balance into household words. Both industry and governments worldwide were endeavoring to manage a flood of continuously evolving data and interpret it for the public under conditions of high uncertainty. What might this recent past mean for our future?